Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 120, Issue 4, Pages 1285-1297Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI36551
Keywords
-
Categories
Funding
- Institut National du Cancer
- Association pour la Recherche contre le Cancer [R07120DP]
- Institut National de la Sante et de la Recherche Medical
- University Pierre et Marie Curie
- University Paris Descartes
- Canceropole Ile de France
- ARC
Ask authors/readers for more resources
Compelling evidence suggests that inflammation, cell survival, and cancer are linked, with a central role played by NF-kappa B. Recent studies implicate some TLRs in tumor development based on their ability to facilitate tumor growth; however, to our knowledge, involvement of neither TLR7 nor TLR78 has yet been demonstrated. Here we have demonstrated expression of TLR7 and TLR8, the natural receptors for single-stranded RNA, by tumor cells in human lung cancer in situ and in human lung tumor cell lines. Stimulation with TLR7 or TLR8 agonists led to activated NF-kappa B, upregulated expression of the antiapoptotic protein Bcl-2, increased tumor cell survival, and chemoresistance. Transcriptional analysis performed on human primary lung tumor cells and TLR7- or TLR8-stimulated human lung tumor cell lines revealed a gene expression signature suggestive of chronic stimulation of tumor cells by TLR ligands in situ. Together, these data emphasize that TLR signaling can directly favor tumor development and further suggest that researchers developing anticancer immunotherapy using TLR7 or TLR8 agonists as adjuvants should take into account the expression of these TLRs in lung tumor cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available